A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Clinical trial NCT06510816 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06510816
- Sponsor
- Annexon, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2026-10-31
- Enrollment
- 659
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.